Synthesis, X-Ray Crystal Structures, Biological Evaluation, and Molecular Docking Studies of a Series of Barbiturate Derivatives
Table 2
Result of in vitro biological evaluation of the synthesized compounds.
Number
DPPH radical scavenging assay IC50 ± SEM (µM)
Anticancer/cytotoxicity assay IC50 ± SEM (µM)
α-Glucosidase inhibition IC50 ± SEM (µM)
Thymidine phosphorylase inhibition IC50 ± SEM (µM)
-Glucuronidase inhibition IC50 ± SEM (µM)
PC3
Hela
MCF-7
3T3
4a
118.8 ± 3.1
>30
>30
NA
>30
NA
NA
204.81 ± 6.0
4b
117 ± 2.4
>30
>30
NA
>30
NA
NA
NA
4c
111.9 ± 1.9
>30
>30
NA
>30
355 ± 10
NA
172.1 ± 2.1
4d
124.4 ± 4.4
>30
>30
NA
>30
NA
230.9 ± 0.8
NA
4e
101.1 ± 0.8
>30
>30
NA
>30
NA
NA
338.9 ± 6.4
4f
148.6 ± 2.6
>30
>30
NA
>30
NA
217.9 ± 2.0
NA
4g
104.1 ± 1.9
>30
>30
NA
>30
NA
NA
NA
4h
133.6 ± 5.7
>30
>30
NA
>30
230 ± 3.9
NA
NA
4i
384.9 ± 6.6
>30
>30
NA
>30
NA
NA
NA
4j
384.3 ± 8.8
>30
>30
NA
>30
NA
NA
NA
4k
NA
>30
>30
NA
>30
NA
182.6 ± 1.0
NA
4l
397.9 ± 0.1
>30
>30
NA
>30
NA
NA
NA
4m
NA
>30
>30
NA
>30
NA
160.2 ± 4.5
NA
4n
NA
>30
>30
NA
>30
NA
226.9 ± 1.5
NA
4o
NA
>30
>30
NA
>30
300.9 ± 6.5
NA
262.1 ± 4.3
4p
NA
>30
>30
NA
>30
186.8 ± 8.1
242.0 ± 1.5
NA
4q
NA
>30
>30
NA
>30
214.8 ± 7.2
141.3 ± 1.5
292.17 ± 1.0
4r
NA
>30
>30
NA
>30
201 ± 5.5
168 ± 1.2
262.1 ± 4.4
4s
439.6 ± 10.1
>30
>30
NA
>30
NA
NA
NA
4t
278.2 ± 10.0
>30
>30
NA
>30
NA
NA
NA
4v
133.2 ± 4.7
>30
>30
NA
>30
NA
57.6 ± 1.2
NA
4w
411.6 ± 0.6
>30
>30
NA
>30
NA
NA
143.5 ± 1.2
4x
388.8 ± 7.9
>30
>30
NA
>30
NA
239 ± 2.0
NA
4y
NA
10.71 ± 0.3
3.47 ± 0.25
4.9 ± 0.01
3.20 ± 0.2
NA
NA
NA
4z
223.0 ± 3.9
>30
>30
NA
>30
NA
55.8 ± 1.5
NA
5a
461.6 ± 8.8
>30
>30
NA
>30
NA
NA
NA
5b
NA
>30
>30
NA
>30
NA
216.9 ± 0.5
NA
5c
NA
>30
>30
NA
>30
NA
161.4 ± 1.5
NA
5d
NA
>30
>30
NA
>30
NA
60.5 ± 1.87
NA
5e
289 ± 0.9
>30
>30
NA
>30
NA
NA
NA
5f
NA
>30
>30
NA
>30
238 ± 9.3
NA
185.0 ± 2.5
5g
270.4 ± 2.3
>30
>30
NA
>30
NA
186.6 ± 1.2
NA
5h
NA
>30
>30
NA
>30
NA
56.9 ± 1.6
NA
5i
NA
>30
>30
NA
>30
NA
NA
323.6 ± 6.4
5j
NA
>30
>30
NA
>30
NA
318 ± 2.5
NA
5k
127.6 ± 1.6
>30
>30
NA
>30
NA
166.4 ± 1.2
NA
5l
169.7 ± 9.3
>30
>30
NA
>30
NA
178.1 ± 2.1
387.5 ± 7.0
5m
NA
>30
>30
NA
>30
453.4 ± 4.2
147.1 ± 1.2
NA
STD.
BHT (28.8 ± 2.1)
Doxorubicin
Doxorubicin
Doxorubicin
Cycloheximide
Acarbose
7-Deazaxanthine
D-Saccharic acid 1-4 lactone
N-acetyl cysteine (107.6 ± 2.8)
0.912 ± 0.12
0.506 ± 0.15
1.56 ± 0.05
0.26 ± 0.1
840 ± 1.73
41 ± 1.64
45.75 ± 2.16
SEM: standard error of mean, PC3: human prostate cancer cell line, HeLa: Henrietta Lacks cervical cancer cell line, MCF-7: Michigan Cancer Foundation-7 breast cancer cell lines, and BHT: butylated hydroxytoluene.
